Wednesday, September 9, 2026
spot_img

Notification of Leadership Changes

UAB “Valstybės investicinis kapitalas” (hereinafter – the Company) announces that, by decision of the Company’s Board of Directors, Mr. Vaidas Daktariūnas has been appointed as Acting CEO effective December 7, 2024. He replaces Mr. Robertas Vyšniauskas, who has stepped down from the CEO position as of that date. This change aligns with the Company’s strategic objectives and will ensure a smooth transition period. The Company extends its gratitude to Mr. Robertas Vyšniauskas for his contributions during his tenure.

The Company is committed to complying with all applicable legal regulations and Nasdaq rules, including the public disclosure of information. Any additional details regarding this decision will be disclosed promptly if required under applicable regulations.

The Board of UAB “Valstybės investicinis kapitalas” remains committed to transparency, principles of responsible management, and safeguarding the interests of shareholders.

For more information: [email protected]

Powered by SlickText.com

Hot this week

Transaction in Own Shares

ICG Enterprise Trust plc (the “Company”) 9 September...

NBPE Announces Transaction in Own Shares

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION...

Total Voting Rights and Transaction in Own Shares

9 September 2026 ICG plc (the “Company”) ...

Pharming Group to participate in September investor conferences

Leiden, the Netherlands, September 9, 2026: Pharming Group N.V. (“Pharming”)...

Topics

Transaction in Own Shares

ICG Enterprise Trust plc (the “Company”) 9 September...

NBPE Announces Transaction in Own Shares

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION...

Total Voting Rights and Transaction in Own Shares

9 September 2026 ICG plc (the “Company”) ...

Pharming Group to participate in September investor conferences

Leiden, the Netherlands, September 9, 2026: Pharming Group N.V. (“Pharming”)...

GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology

Simple, reliable and scalable blood-based testing could identify patients...
spot_img

Related Articles

Popular Categories

spot_img